Diagnostic procedure for the determination of the Nox2 protein

Patent number:

EP3495821A1

Italia.svg
No items found.

A diagnostic method for the quantitative detection of the Nox2 protein in a biological sample, comprises the following operations i) normalize the protein content of the biological sample to a value of 1 μg of protein per 100 μl of the sample, ii) put in contacting the normalized biological sample with an anti-Nox2 monoclonal detection antibody, wherein the detection antibody is directly conjugated to a detection label, and iii) detecting the formation of the Nox2 protein-detection antibody complex

Countries:
Italy
Regions:
No items found.
Centers:
SAPIENZA UNIVERSITA DI ROMA
Other entities:
Sectors:
Health
Subsectors:
Biotechnology, Measurement, Analysis of biological materials
TRL Level:
TRL 7 – system prototype demonstration in operational environment
BRL Level:
BRL1: Hypothesizing on possible business concept
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

This patent is applicable in the field of cardiovascular and inflammatory disease. In particular, analysing this biomarker (sNox2-dp) by ELISA kit is essential to stratify the cardiovascular and inflammatory risk.

Comments

Other related patents

Health
Chemicals

APPLICATIONS OF THE PROTEIN MUNS AND THE DERIVATES THEREOF

Countries
Spain
Know more
Health
Chemicals

CRYOPROTECTANT AND/OR CRYOPRESERVANT COMPOSITION, METHODS AND USES THEREOF

Countries
Portugal
Know more
Health

Method for liquefying a respiratory sample and for the subsequent detection of respiratory infections in said sample

Countries
Spain
Know more
Get back to patents directory